JPH01115902A - Production of hyaluronic acid - Google Patents

Production of hyaluronic acid

Info

Publication number
JPH01115902A
JPH01115902A JP27319487A JP27319487A JPH01115902A JP H01115902 A JPH01115902 A JP H01115902A JP 27319487 A JP27319487 A JP 27319487A JP 27319487 A JP27319487 A JP 27319487A JP H01115902 A JPH01115902 A JP H01115902A
Authority
JP
Japan
Prior art keywords
hyaluronic acid
paste
making
protease
followed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27319487A
Other languages
Japanese (ja)
Inventor
Yasuko Yoshizawa
吉沢 康子
Koji Yamada
浩司 山田
Fumio Fukui
福井 史生
Shinobu Muto
武藤 忍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IJICHI SHIYUKEIJIYOU KK
Showa Sangyo Co Ltd
Original Assignee
IJICHI SHIYUKEIJIYOU KK
Showa Sangyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IJICHI SHIYUKEIJIYOU KK, Showa Sangyo Co Ltd filed Critical IJICHI SHIYUKEIJIYOU KK
Priority to JP27319487A priority Critical patent/JPH01115902A/en
Publication of JPH01115902A publication Critical patent/JPH01115902A/en
Pending legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE:To obtain in high yield high-viscosity and high-purity hyaluronic acid useful as a base material for drugs and cosmetics, by chopping and making the raw material into a paste while keeping in a freezed state and sterilizing the product at high temperatures for a short time followed by quenching and then making a protease treatment. CONSTITUTION:A raw material containing large quantities of hyaluronic acid such as cockscombs, skins or synovial fluid is rapidly freezed followed by chopping with, e.g., a meat chopper and then making the product into a paste using, e.g., a homogenizer, ultrafine grinder. This paste is then sterilized normally at 70-140 deg.C for pref. 1sec-10min followed by quenching and then performing treatment with a protease (e.g., papain, trypsin, alkalase), thus obtaining the objective hyaluronic acid. This hyaluronic acid can be prevented from quality deterioration due to hyaluronidase or prolonged heating, thus enabling improvement of its quality and yield along with significant reduction in its treatment time.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は高分子のヒアルロン酸を高純度、かつ高収率で
製造する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a method for producing high-molecular hyaluronic acid with high purity and high yield.

(従来の技術とその問題点) ヒアルロン酸は、アミノ糖とウロン酸から成る複雑な多
糖類の一種である。動物諸組織、特に間充組織に広く分
布し、硝子体、水様液、ヘソの緒、関節液、肋膜液、皮
膚、ニワトリの鶏冠(いわゆるトサカ)等に多く含まれ
、動物組織にあっては、遊離酸および塩としてゲル状を
なして細胞間、および繊維間を埋める結合物質である。
(Prior art and its problems) Hyaluronic acid is a type of complex polysaccharide consisting of amino sugar and uronic acid. It is widely distributed in animal tissues, especially mesenchymal tissues, and is abundant in the vitreous body, aqueous fluid, umbilical cord, joint fluid, pleural fluid, skin, chicken comb (so-called comb), etc. is a binding substance that forms a gel as a free acid and salt and fills the spaces between cells and fibers.

粘稠性、保水性、潤滑性等の性質を有するヒアルロン酸
は、医薬や化粧品基材として需要が多く、高粘度、高純
度のものが要求される。
Hyaluronic acid, which has properties such as viscosity, water retention, and lubricity, is in high demand as a base material for medicines and cosmetics, and high viscosity and high purity are required.

従来、ヒアルロン酸を得るには、原料を水で抽出して得
た水溶液から塩化セチルピリジニウムで沈澱させ、塩化
す)リウム溶液に溶解して、さらにエタノールで再沈澱
する方法が基本的方法として知られている。
Conventionally, the basic method for obtaining hyaluronic acid is to extract the raw material with water, precipitate it with cetylpyridinium chloride from the aqueous solution, dissolve it in a lium chloride solution, and then reprecipitate with ethanol. It is being

収率良く品質の良いヒアルロン酸を大量に製造するため
には、原料を前処理する必要があることから、多くの方
法が提案されている。例えば、結合組織をその形状のま
ま約70〜130℃に加熱処理した後に蛋白質分解酵素
処理し、常法により処理する方法(特公昭60−904
2号公l) 、鶏冠をその形状のまま、または裁断して
35〜65℃で加温後帯白質分解酵素処理を行い、以下
常法により処理する方法(特公昭61−8083号公報
)、予め加熱処理したヒアルロン酸含有原料をペースト
化した後、プロテアーゼ処理する方法(特開昭60−2
4194号公報)等がある。
In order to produce large quantities of high-yield, high-quality hyaluronic acid, it is necessary to pre-treat raw materials, and many methods have been proposed. For example, connective tissue is heated to approximately 70 to 130°C in its original form, then treated with proteolytic enzymes, and then treated using conventional methods (Japanese Patent Publication No. 60-904).
No. 2 Publication No. 1), a method in which a cock's comb is left in its shape or cut into pieces, heated at 35 to 65°C, treated with a leukolytic enzyme, and then treated using a conventional method (Japanese Patent Publication No. 8083/1983); A method in which hyaluronic acid-containing raw materials that have been heat-treated in advance are made into a paste and then treated with protease (Japanese Patent Laid-Open No. 60-2
4194) etc.

これらの方法は、いずれも大量に製造する方法として簡
単で効率の良い方法であるが、原料および製造工程中に
混入するヒアルロニダーゼが、ヒアルロン酸の低分子化
に作用し、また、長時間の加熱により品質を低下する等
の問題があった。
All of these methods are simple and efficient methods for mass production, but hyaluronidase mixed into the raw materials and during the manufacturing process reduces the molecular weight of hyaluronic acid, and they require long-term heating. There were problems such as deterioration of quality.

本発明は、このようなヒアルロニダーゼによる品質の低
下を防止し、収率の良いヒアルロン酸の製造法を提供す
ることを目的とする。
An object of the present invention is to provide a method for producing hyaluronic acid with good yield and preventing such quality deterioration caused by hyaluronidase.

(問題点を解決するための手段) 本発明のヒアルロン酸の製造法は、原料を急速冷凍し、
凍結状態のまま細断・ペースト化した後、高温で短時間
殺菌し急速冷却後、プロテアーゼ処理し、続いて常法に
より処理するすることを特徴とする。
(Means for solving the problems) The method for producing hyaluronic acid of the present invention includes rapidly freezing raw materials,
It is characterized in that it is shredded and made into a paste in a frozen state, then sterilized at high temperature for a short time, rapidly cooled, treated with protease, and then processed by a conventional method.

原料としては、ヒアルロン酸を多量に含む結合組織を用
いる。このような原料としては、鶏冠、皮膚、項靭帯、
関節液、―帯、血管壁、軟骨、硝子体等があげられ、特
に多量に入手が容易な鶏冠が好ましい。
As a raw material, connective tissue containing a large amount of hyaluronic acid is used. Such raw materials include chicken comb, skin, nuchal ligament,
Examples include synovial fluid, zona, blood vessel walls, cartilage, vitreous body, etc., and cockscomb is particularly preferred since it is easily available in large quantities.

原料は、採取後、直ちに急速冷凍する。原料は、採取し
て日数を経るにしたがってヒアルロニダーゼにより品質
低下を生ずるので、これを防止するためである。
Raw materials are quickly frozen immediately after collection. This is to prevent the quality of raw materials from deteriorating due to hyaluronidase over time after they are collected.

凍結した原料は、解凍することな(、そのまま細断し、
ペースト化する。細断には、通常の方法を用いることが
でき、例えばミートチョッパー等で充分である。ペース
ト化には、ホモゲナイザー、超微粒粉砕機(スーパーマ
スコロイダー等)などを用い、必要に応じて水、または
フレーク状氷を加え流動性を保持する。ペーストの温度
上昇を抑えるため約10℃以下で操作することが好まし
く、特に2℃以下におさえることが好ましい。細断・ペ
ースト化によってヒアルロン酸の抽出の効率化を図るこ
とができる。
Do not thaw frozen raw materials (shred them as they are,
Make a paste. For shredding, a conventional method can be used; for example, a meat chopper or the like is sufficient. To make a paste, use a homogenizer, an ultrafine crusher (such as a supermass colloider), and add water or ice flakes as necessary to maintain fluidity. In order to suppress the rise in temperature of the paste, it is preferable to operate at a temperature of about 10°C or less, particularly preferably 2°C or less. The efficiency of extracting hyaluronic acid can be improved by cutting it into pieces and making it into a paste.

次いで、ペーストを高温で短時間殺菌するが、温度は例
えば70〜140℃で1秒〜10分の短時間で処理する
ことが好ましい。高温で短時間殺菌した後は、急速冷却
する。この工程で、ヒアルロニダーゼは、完全に失活し
、以降の操作中での品質の低下を防止できる。しかも短
時間で処理するため、従来のような長時間加熱による品
質の低下は生じない。
Next, the paste is sterilized at high temperature for a short time, preferably at a temperature of 70 to 140° C. for a short time of 1 second to 10 minutes. After sterilization at high temperatures for a short period of time, it is rapidly cooled. In this step, hyaluronidase is completely inactivated, and quality deterioration during subsequent operations can be prevented. Moreover, since the process is carried out in a short time, there is no deterioration in quality due to long heating times as in conventional methods.

プロテアーゼ処理に用いる酵素としては、例えばパパイ
ン、フィシン、ブロメライン等の植物起源酵素、トリプ
シン、キモトリプシン等の動物起源酵素、プロリシン、
アクチナーゼ、アルカラーゼ、ニュートラーゼ等の微生
物起源酵素等があげられる。これらの酵素は一種のみを
単独で用いることもできるが、性質の異なる酵素を複数
種混合し併用するならば、1種の酵素で処理したり或い
は複数回にわたって複数種の酵素で処理する場合よりも
、処理時間の短縮を図ることができ、しかも純度および
収率が向上するので特に有利である。
Enzymes used for protease treatment include, for example, plant-derived enzymes such as papain, ficin, and bromelain, animal-derived enzymes such as trypsin and chymotrypsin, prolysin,
Examples include microbial enzymes such as actinase, alcalase, and neutrase. Although it is possible to use only one type of these enzymes alone, if multiple types of enzymes with different properties are mixed and used together, the treatment will be more effective than when treated with one type of enzyme or multiple times with multiple types of enzymes. This method is particularly advantageous because it can shorten processing time and improve purity and yield.

プロテアーゼ処理後は、常法により処理する。After the protease treatment, a conventional method is used.

例えば、遠心分離または濾過により、精製した後、上澄
み液または濾液に第4級アンモニウム塩(例えば塩化セ
チルピリジニウム)を添加する。得られた沈澱物を食塩
水等に再溶解し、エタノールを添加後、沈澱物を採取し
、乾燥する。
After purification, for example by centrifugation or filtration, a quaternary ammonium salt (eg cetylpyridinium chloride) is added to the supernatant or filtrate. The obtained precipitate is redissolved in a saline solution or the like, and after adding ethanol, the precipitate is collected and dried.

(発明の効果) 本発明によれば、原料を凍結状態のまま細断・ペースト
化し、高温短時間殺菌し、プロテアーゼにより処理する
ことを特徴とするので、ヒアルロニダーゼによる品質低
下や、長時間加熱による品質低下を防止でき、品質や収
率の向上を図ることができると共に、処理時間を大幅に
短縮できる。
(Effects of the Invention) According to the present invention, the raw material is shredded and made into a paste in a frozen state, sterilized at high temperature for a short time, and treated with protease. It is possible to prevent quality deterioration, improve quality and yield, and significantly shorten processing time.

(実施例) 実施例1 屠殺直後に採取した鶏冠を噴霧式冷凍装置を用い、液体
窒素で急速冷凍した。該冷凍鶏冠1 kgを゛ミートチ
ョッパーにより細断した。これにフレーク状の氷2 k
gを添加し、スーパーマスコロイダ−(増幸産業al製
)でペースト化した。得られたペーストを130℃にて
3秒間瞬間殺菌し、直ちに急速冷却した。水を21加え
、pHを7.0に調整し、プロテアーゼとして、アクチ
ナーゼE(科研製薬■製)30曙を加え、50℃で3時
間インキュベートした。次いで、得られた溶液を濾過し
、濾液を3゜21得た。この濾液に5 (w/v)%塩
化セチルピリジニウム液600iを加えた。生成した沈
澱物を濾取し、0.5Mの塩化ナトリウム溶液に再溶解
した。
(Examples) Example 1 A chicken comb collected immediately after slaughter was quickly frozen in liquid nitrogen using a spray freezing device. 1 kg of the frozen chicken comb was shredded using a meat chopper. Add 2k flaky ice to this
g was added thereto, and the mixture was made into a paste using Super Mascolloider (manufactured by Masuko Sangyo Al). The resulting paste was flash sterilized at 130° C. for 3 seconds and immediately rapidly cooled. Water was added at 21°C to adjust the pH to 7.0, and 300ml of actinase E (manufactured by Kaken Pharmaceutical Co., Ltd.) was added as a protease, followed by incubation at 50°C for 3 hours. The resulting solution was then filtered to obtain 3.21 ml of filtrate. To this filtrate was added 600 i of 5 (w/v)% cetylpyridinium chloride solution. The formed precipitate was collected by filtration and redissolved in 0.5M sodium chloride solution.

この溶液にエタノールを60 (v/v)%になるよう
に添加し、生成した沈澱物を濾取し乾燥した。
Ethanol was added to this solution at a concentration of 60 (v/v)%, and the resulting precipitate was collected by filtration and dried.

実施例2 実施例1と同様に処理して得られたペーストを用い、1
00℃にて300秒間瞬殺菌し、直ちに急速冷却した。
Example 2 Using a paste obtained by processing in the same manner as in Example 1, 1
It was flash sterilized at 00°C for 300 seconds and immediately rapidly cooled.

水を2β加え、p Hを7.0に調整し、プロテアーゼ
として、アクチナーゼE 15mgおよびニュートラー
ゼ0.5L (ノボインダストリー・ジャパン■製)0
.5mlを添加し、55℃で2時間インキュベートした
。次いで、得られた溶液を濾過し、実施例1と同様に処
理した。
Add 2β of water, adjust the pH to 7.0, and use 15 mg of actinase E and 0.5 L of Neutrase (manufactured by Novo Industries Japan) as protease.
.. 5 ml was added and incubated at 55°C for 2 hours. The resulting solution was then filtered and treated as in Example 1.

比較例1 得られたペーストを130℃にて3秒間瞬間殺菌する代
わりに、60℃にて30分間殺菌した以外は、実施例1
と同様に処理してヒアルロン酸を得た。
Comparative Example 1 Example 1 except that the resulting paste was sterilized at 60°C for 30 minutes instead of being instantaneously sterilized at 130°C for 3 seconds.
Hyaluronic acid was obtained in the same manner as above.

この比較例では、ヒアルロニダーゼの失活が不充分であ
った。
In this comparative example, hyaluronidase was insufficiently deactivated.

比較例2 冷凍鶏冠を緩慢解凍したものを原料として用いた以外は
、実施例1と同様に処理してヒアルロン酸を得た。
Comparative Example 2 Hyaluronic acid was obtained in the same manner as in Example 1, except that slowly thawed frozen chicken combs were used as the raw material.

比較例3 冷凍鶏冠1 kgに水11を加え、95℃にて45分間
加熱した。固形物を取り出し、ミンチにした後、水41
を加え、pHを7.0に調整した以外は、プロテアーゼ
処理以降は、実施例1と同様に処理してヒアルロン酸を
得た。
Comparative Example 3 11 parts of water was added to 1 kg of frozen chicken comb, and the mixture was heated at 95°C for 45 minutes. After removing the solids and mincing them, add 41 liters of water.
After the protease treatment, hyaluronic acid was obtained in the same manner as in Example 1, except that the pH was adjusted to 7.0.

実施例および比較例で得られたヒアルロン酸の収量、純
度、分子量を第1表に示す。
Table 1 shows the yield, purity, and molecular weight of hyaluronic acid obtained in Examples and Comparative Examples.

第1表 注 1)カルバゾール硫酸法で測定したウロン酸量に2
.06を乗じて算出。
Table 1 Note 1) The amount of uronic acid measured by the carbazole sulfuric acid method is
.. Calculated by multiplying by 06.

2)ウベローデ型粘度計を用いて測定した極限粘度から
算出。
2) Calculated from the intrinsic viscosity measured using an Ubbelohde viscometer.

実施例3 原料として急速冷凍した豚皮(1kg)を用い、加熱処
理条件を100℃で30秒、プロテアーゼ処理を水32
添加後アルカラーゼ0.6L、ニュートラーゼ0.5L
 (いずれもノボインダストリー・ジャパン■製)各l
 mlを加え、50℃で7時間インキュベート、とそれ
ぞれ変更した以外は、実施例1に準拠した一連の操作を
行って豚皮起源のヒアルロン酸を取得した。収量は3.
1g、上記例と同様に測定した純度は89.6%および
分子量は17万であった。
Example 3 Quick-frozen pig skin (1 kg) was used as a raw material, heat treatment was performed at 100°C for 30 seconds, and protease treatment was performed using water for 32 seconds.
After addition Alcalase 0.6L, Neutrase 0.5L
(All manufactured by Novo Industries Japan) 1 liter each
Hyaluronic acid derived from pig skin was obtained by carrying out a series of operations according to Example 1, except for adding ml and incubating at 50° C. for 7 hours. The yield is 3.
1 g, the purity measured in the same manner as in the above example was 89.6%, and the molecular weight was 170,000.

Claims (1)

【特許請求の範囲】[Claims] 原料を急速冷凍し、凍結状態のまま細断・ペースト化し
た後、高温で短時間殺菌し急速冷却後、プロテアーゼ処
理し、続いて常法により処理することを特徴とするヒア
ルロン酸の製造法。
A method for producing hyaluronic acid, which is characterized in that raw materials are rapidly frozen, shredded and made into a paste in a frozen state, then sterilized at high temperature for a short period of time, rapidly cooled, treated with protease, and then treated by a conventional method.
JP27319487A 1987-10-30 1987-10-30 Production of hyaluronic acid Pending JPH01115902A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27319487A JPH01115902A (en) 1987-10-30 1987-10-30 Production of hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27319487A JPH01115902A (en) 1987-10-30 1987-10-30 Production of hyaluronic acid

Publications (1)

Publication Number Publication Date
JPH01115902A true JPH01115902A (en) 1989-05-09

Family

ID=17524412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27319487A Pending JPH01115902A (en) 1987-10-30 1987-10-30 Production of hyaluronic acid

Country Status (1)

Country Link
JP (1) JPH01115902A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621093A (en) * 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
JP2003048403A (en) * 2001-08-08 2003-02-18 Toyota Motor Corp Vehicle wheel structure
WO2012033189A1 (en) 2010-09-10 2012-03-15 参天製薬株式会社 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
WO2012176865A1 (en) 2011-06-23 2012-12-27 参天製薬株式会社 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
CN105461825A (en) * 2015-12-24 2016-04-06 杭州嘉伟生物制品有限公司 Method for increasing yield of medical sodium hyaluronate refined product
JP2017019822A (en) * 2010-07-28 2017-01-26 オルス、ファルマHorus Pharma Topical preservative-free composition containing hyaluronic acid

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621093A (en) * 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
JP2003048403A (en) * 2001-08-08 2003-02-18 Toyota Motor Corp Vehicle wheel structure
JP2017019822A (en) * 2010-07-28 2017-01-26 オルス、ファルマHorus Pharma Topical preservative-free composition containing hyaluronic acid
WO2012033189A1 (en) 2010-09-10 2012-03-15 参天製薬株式会社 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
US9006208B2 (en) 2010-09-10 2015-04-14 Santen Pharmaceutical Co., Ltd. Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof
WO2012176865A1 (en) 2011-06-23 2012-12-27 参天製薬株式会社 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
CN105461825A (en) * 2015-12-24 2016-04-06 杭州嘉伟生物制品有限公司 Method for increasing yield of medical sodium hyaluronate refined product

Similar Documents

Publication Publication Date Title
Nalinanon et al. Improvement of gelatin extraction from bigeye snapper skin using pepsin-aided process in combination with protease inhibitor
CN102690370B (en) Comprehensive utilization technique of marine fish bones
EP2459011A1 (en) Preparation of high purity collagen
CN112778412B (en) Preparation method of low-endotoxin collagen
CN111363772A (en) Method for preparing collagen peptide by hydrolyzing bovine bone and collagen peptide thereof
CN101570772A (en) Method for preparing natural ossein
US20190281851A1 (en) Pure Collagen Milk Powder and Preparation Method Thereof
CN105985429A (en) Aseptic collagen liquid with biological activity and preparation method thereof
CN110592053A (en) Collagen hydrolysis complex enzyme, protein oligopeptide and preparation method thereof
CN112079913A (en) Process for extracting non-denatured type II collagen from sturgeon cartilage
JP2004149736A (en) Chondroitin sodium sulfate, chondroitin sulfate-containing substance, and method for producing them
CN110564802A (en) Extraction method of yak achilles tendon bone collagen
JPH01115902A (en) Production of hyaluronic acid
JPS5837001A (en) Production of hyaluronic acid
WO2023082523A1 (en) Method for improving extraction rate of chondroitin sulfate prepared from tilapia skull
CN103740793B (en) A kind of method of producing collagen of fish skin
JPH01115903A (en) Production of hyaluronic acid
CN112760351A (en) Extraction method and application of fish skin collagen
KR100706294B1 (en) Low-Molecular Chondroitin Sulfate Obtained from Cartilage of Cartilaginous Fish and Its Manufacturing Method
JP5263870B2 (en) Method for producing collagen peptide
JPH07241200A (en) Production of hyaluronic acid
JP2000270806A (en) Kelp extract and its production method
KR101837118B1 (en) A Method for Extracting Collagen using Bacterial Fermentation
JP2516009B2 (en) Method for producing hyaluronic acid
CN105876072A (en) Method for increasing solubility of rice protein